| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/22/2004 | CN1530132A Tianfang xifeng huagu pillets |
| 09/22/2004 | CN1530123A Chinese medicine for treating acute appendicitis and chronic appendicitis, preparing method thereof |
| 09/22/2004 | CN1530121A Preparation of manyprickle acanthopanax capsules |
| 09/22/2004 | CN1530118A Tonifying Yang wine |
| 09/22/2004 | CN1530112A Medicine for preventing fibrous liver and preparing method thereof |
| 09/22/2004 | CN1530104A Sustained releasing talbets for radioactive and chemical therpay and preparation thereof |
| 09/22/2004 | CN1167698C New N-triazolyl methyl piperazine derivative using as neurokinin receptor antagonistic agent |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands |
| 09/22/2004 | CN1167680C Fused-ring compounds and use thereof as drugs |
| 09/22/2004 | CN1167670C Aryl carboxylic acid and tetrazole derivant |
| 09/22/2004 | CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/22/2004 | CN1167465C Fusion anticaries DNA vaccine and its preparation |
| 09/22/2004 | CN1167460C Medicine for infant to invigorate sipleen and expel stagnation and its preparing process |
| 09/22/2004 | CN1167457C Instant powder containing Radix Astragalus seu hedysari, Herba Dendrobii, Frutus crataegi, and its preparation |
| 09/22/2004 | CN1167454C Chinese medicine for detoxication and its preparation |
| 09/22/2004 | CN1167447C Oral taken Chinese medicine preparation for constipation |
| 09/22/2004 | CN1167443C Liquid medicie for preventing and curing dental caries and edontopathy and its preparing process |
| 09/22/2004 | CN1167440C Chinese herbal medicinal composition for smoothing liver and detoxication |
| 09/22/2004 | CN1167438C Capsules for tonifying kidney and tranquilization and their preparation |
| 09/22/2004 | CN1167436C Snuff for treating toothache |
| 09/22/2004 | CN1167434C Health-care food with functions of protecting liver and resisting osteoporosis |
| 09/22/2004 | CN1167425C Use of amioaglycon antibiotics in preparing compound oral liquid for treating gastroenteritis |
| 09/22/2004 | CN1167415C Orally applied solid preparation of medicine difficult to dissolve |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794510 Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
| 09/21/2004 | US6794405 Alicyclic imidazoles as H3 agents |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794398 Preventive/remedies for liver diseases |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794388 Succinic acid salts of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794380 Amide derivatives |
| 09/21/2004 | US6794178 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 09/21/2004 | US6793939 Tissue graft composition comprising liver basement membrane; graft composition can be implanted to replace or induce repair of damaged or diseased tissues |
| 09/21/2004 | US6793921 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 09/21/2004 | CA2317673C Novel allylthiopyridazine derivatives and process for preparing the same |
| 09/21/2004 | CA2167673C Condensed benzazepine derivative and pharmaceutical composition thereof |
| 09/16/2004 | WO2004078751A1 Benzofuran derivative |
| 09/16/2004 | WO2004078719A1 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 09/16/2004 | WO2004078695A1 Method for the purification of crocetin |
| 09/16/2004 | WO2004078217A1 Bone calcification promoter |
| 09/16/2004 | WO2004078209A1 Composition and method for the treatment and prevention of enteric bacterial infections |
| 09/16/2004 | WO2004078191A1 Composition for treating hepatitis c |
| 09/16/2004 | WO2004078188A1 COMPOSITION CONTAINING β-GLUCAN AND CONSTIPATION-RELIEVING DRUG, IMMUNOPOTENTIATOR AND SKIN MOISTENING AGENT USING THE COMPOSITION |
| 09/16/2004 | WO2004078175A2 Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of ip-10 mediated diseases |
| 09/16/2004 | WO2004078172A2 Sod mimic multifunctional compounds for treating inflammatory bowel disease |
| 09/16/2004 | WO2004078169A1 Use of ep2 selective receptor agonists in medical treatment |
| 09/16/2004 | WO2004067027A3 Osteogenic composition |
| 09/16/2004 | WO2004067024A3 Hcv combination therapy |
| 09/16/2004 | WO2004062688A3 Use of cc-chemokine mutants against liver diseases |
| 09/16/2004 | WO2004012655A3 Anti-microbial compositions and methods of using same |
| 09/16/2004 | WO2003105776A3 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 09/16/2004 | WO2003096989A3 Anti tubercular drug: compositions and methods |
| 09/16/2004 | WO2003074128A3 Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds |
| 09/16/2004 | WO2003062265A3 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003045228A9 Methods for treating autoimmune disorders, and reagents related thereto |
| 09/16/2004 | WO2003043583A3 Treatment of immunological disorders using anti-cd30 antibodies |
| 09/16/2004 | WO2002050097A3 Anti-allergic complex molecules |
| 09/16/2004 | US20040181076 Reaction of carbazolone, forrmaldehyde and amine compound in nonaqueous solution and bonding to water, solvent |
| 09/16/2004 | US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181035 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 09/16/2004 | US20040180968 Methods for the treatment and prevention of pancreatitis and for induction of liver regeneration |
| 09/16/2004 | US20040180963 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 09/16/2004 | US20040180962 Dosage forms having prolonged active ingredient release |
| 09/16/2004 | US20040180953 B form is the most thermodynamically stable form at room temperature; a purer and more homogeneous product is produced and recrystallization is advantageously carried out by initiating with a small amount of the product |
| 09/16/2004 | US20040180944 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 09/16/2004 | US20040180935 in a solid dosage form for oral administration, such as a tablet; preventing or treating a disease that is associated with excess gastric acid secretion |
| 09/16/2004 | US20040180925 such as (S)-1-[2-(2-Pyrazinylamino)ethylamino]acetyl-2-pyrrolidinecarbonitrile dimethanesulfonate |
| 09/16/2004 | US20040180920 Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the treatment of gastrointestinal disorders |
| 09/16/2004 | US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable |
| 09/16/2004 | US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 09/16/2004 | US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine |
| 09/16/2004 | US20040180876 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis |
| 09/16/2004 | US20040180850 Polysaccharides with Helicobacter pylori receptor activity; preventing bacteria adhesion; stabilizing gastrointestinal mucus layer against ulcer causing agents |
| 09/16/2004 | US20040180843 Treatment of helicobacter with isothocyanates |
| 09/16/2004 | US20040180836 Blocking peptide for inflammatory cell secretion |
| 09/16/2004 | US20040180834 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 09/16/2004 | US20040180818 adiponectin (adipose specific protein); suppressing fibrosis during regrowth; inhibiting TGFB and PDGF action on hepatic stellate cells; cirrhosis repair |
| 09/16/2004 | US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome) |
| 09/16/2004 | US20040180053 Binding protein |
| 09/16/2004 | US20040180007 Pharmaceutical chewing gum formulations |
| 09/16/2004 | US20040177804 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 09/16/2004 | DE20320528U1 Neue Kristallformen von Ondansetron und Arzneimittel, welche die neuen Formen enthalten New crystal forms of ondansetron and pharmaceutical compositions containing the new forms |
| 09/16/2004 | CA2518199A1 Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications |
| 09/16/2004 | CA2518193A1 Use of ep2 selective receptor agonists in medical treatment |
| 09/16/2004 | CA2517911A1 Composition and method for the treatment and prevention of enteric bacterial infections |
| 09/16/2004 | CA2517136A1 Composition for treating hepatitis c |
| 09/16/2004 | CA2512280A1 Benzofuran derivative |
| 09/15/2004 | EP1457557A1 Novel proteins and dnas thereof |
| 09/15/2004 | EP1457493A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists |